This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
AAFP Provisional Recommendations for use of Tdap AND guidance on use of Tdap for adults aged 65 years and older
The American Academy of Family Physicians has adopted the provisional recommendations for the Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) which is consistent with that of the Advisory Committee on Immunization Practices (ACIP), which advises the Centers for the Disease Control and Prevention (CDC) on immunizations. The provisional recommendation of the ACIP is located on the CDC website: http://www.cdc.gov/vaccines/recs/provisional/Tdap-feb2012.htm
The Tdap provisional recommendations are:
* For adults aged 19 years and older who previously have not received a dose of Tdap, a single dose of Tdap should be given.
* Tdap should be administered regardless of interval since the last tetanus or diphtheria toxoid-containing vaccine.
* Adults should receive a Tdap dose if the dose is recommended and no record of previous administration exists.
Guidance on use of Tdap products for adults aged 65 years and older:
* Providers should not miss an opportunity to vaccinate persons aged 65 years and older with Tdap, and may administer the vaccine that they have available.
* When feasible, for adults aged 65 years and older, Boostrix should be used; however, either vaccine product administered to a person aged 65 years and older provides protection and is considered valid.
Recommendations for use of Tdap for adults aged 65 years and older
Pertussis Vaccination Outreach Letter (*PDF file)
From the CDC